NO20074101L - Isolering av CCI-779 fra morvaesker - Google Patents

Isolering av CCI-779 fra morvaesker

Info

Publication number: NO20074101L
Authority: NO; Norway
Prior art keywords: cci; isolation; mother liquids; mother; liquids
Prior art date: 2005-03-02

Application number

NO20074101A

Other languages

English (en)

Norwegian (no)

Inventor

Bogdan Kazimierz Wilk

Warren Chew

Chia-Cheng Shaw

Genevieve Fortier

Original Assignee

Wyeth Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-03-02

Filing date

2007-08-08

Publication date

2007-09-26

2007-08-08 Application filed by Wyeth Corp filed Critical Wyeth Corp

2007-09-26 Publication of NO20074101L publication Critical patent/NO20074101L/no

Links

CBPNZQVSJQDFBE-FUXHJELOSA-N Temsirolimus Chemical compound C1C[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 CBPNZQVSJQDFBE-FUXHJELOSA-N 0.000 title abstract 2
229960000235 temsirolimus Drugs 0.000 title abstract 2
238000002955 isolation Methods 0.000 title 1
239000007788 liquid Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/18—Bridged systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
- C12P17/188—Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Wood Science & Technology (AREA)
Health & Medical Sciences (AREA)
Zoology (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Health & Medical Sciences (AREA)
Biochemistry (AREA)
Genetics & Genomics (AREA)
General Engineering & Computer Science (AREA)
Biotechnology (AREA)
Bioinformatics & Cheminformatics (AREA)
Microbiology (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Separation Using Semi-Permeable Membranes (AREA)
Extraction Or Liquid Replacement (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Saccharide Compounds (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Treating Waste Gases (AREA)
Inorganic Compounds Of Heavy Metals (AREA)
Physical Or Chemical Processes And Apparatus (AREA)

NO20074101A 2005-03-02 2007-08-08 Isolering av CCI-779 fra morvaesker NO20074101L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US65753405P	2005-03-02	2005-03-02
PCT/US2006/006207 WO2006093743A1 (en)	2005-03-02	2006-02-22	Recovery of cci-779 from mother liquors

Publications (1)

Publication Number	Publication Date
NO20074101L true NO20074101L (no)	2007-09-26

Family

ID=36602445

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20074101A NO20074101L (no)	2005-03-02	2007-08-08	Isolering av CCI-779 fra morvaesker

Country Status (21)

Country	Link
US (1)	US7288647B2 (zh)
EP (1)	EP1853611A1 (zh)
JP (1)	JP2008531685A (zh)
KR (1)	KR20070107072A (zh)
CN (1)	CN101133066A (zh)
AR (1)	AR053151A1 (zh)
AU (1)	AU2006218916A1 (zh)
BR (1)	BRPI0607390A2 (zh)
CA (1)	CA2599580A1 (zh)
CR (1)	CR9325A (zh)
GT (1)	GT200600095A (zh)
IL (1)	IL185078A0 (zh)
MX (1)	MX2007010715A (zh)
MY (1)	MY138328A (zh)
NI (1)	NI200700226A (zh)
NO (1)	NO20074101L (zh)
PE (1)	PE20061293A1 (zh)
RU (1)	RU2007130407A (zh)
TW (1)	TW200643023A (zh)
WO (1)	WO2006093743A1 (zh)
ZA (1)	ZA200707526B (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1957500A1 (en) *	2005-12-07	2008-08-20	Wyeth a Corporation of the State of Delaware	Process for the preparation of purified crystalline cci-779
US7622578B2 (en) *	2005-12-07	2009-11-24	Wyeth	Scalable process for the preparation of a rapamycin 42-ester from a rapamycin 42-ester boronate
AR058283A1 (es) *	2005-12-07	2008-01-30	Wyeth Corp	Metodos para la preparacion de rapamicina cristalina y para la medicion de la cristalinidad de los compuestos de rapamicina utilizando calorimetria diferencial de barrido
US20070203169A1 (en) *	2006-02-28	2007-08-30	Zhao Jonathon Z	Isomers and 42-epimers of rapamycin ester analogs, methods of making and using the same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3993749A (en)	1974-04-12	1976-11-23	Ayerst Mckenna And Harrison Ltd.	Rapamycin and process of preparation
US5362718A (en) *	1994-04-18	1994-11-08	American Home Products Corporation	Rapamycin hydroxyesters
US6277983B1 (en)	2000-09-27	2001-08-21	American Home Products Corporation	Regioselective synthesis of rapamycin derivatives
BRPI0412659A (pt)	2003-07-16	2006-09-26	Wyeth Corp	isÈmero c de cci-779, seu processo de preparação, composição farmacêutica compreendendo o mesmo e pacote farmacêutico contendo o referido composto
WO2005016935A2 (en) *	2003-08-07	2005-02-24	Wyeth	Regioselective synthesis of cci-779
US20060015840A1 (en) *	2004-03-31	2006-01-19	Wendall Marvel	Parameter-based software development, distribution, and disaster recovery

2006
- 2006-02-22 CA CA002599580A patent/CA2599580A1/en not_active Abandoned
- 2006-02-22 KR KR1020077019582A patent/KR20070107072A/ko not_active Application Discontinuation
- 2006-02-22 RU RU2007130407/04A patent/RU2007130407A/ru not_active Application Discontinuation
- 2006-02-22 US US11/359,842 patent/US7288647B2/en not_active Expired - Fee Related
- 2006-02-22 JP JP2007558061A patent/JP2008531685A/ja not_active Withdrawn
- 2006-02-22 WO PCT/US2006/006207 patent/WO2006093743A1/en active Application Filing
- 2006-02-22 CN CNA200680006613XA patent/CN101133066A/zh not_active Withdrawn
- 2006-02-22 AU AU2006218916A patent/AU2006218916A1/en not_active Abandoned
- 2006-02-22 BR BRPI0607390A patent/BRPI0607390A2/pt not_active IP Right Cessation
- 2006-02-22 MX MX2007010715A patent/MX2007010715A/es active IP Right Grant
- 2006-02-22 EP EP06735741A patent/EP1853611A1/en not_active Withdrawn
- 2006-02-27 GT GT200600095A patent/GT200600095A/es unknown
- 2006-02-27 TW TW095106494A patent/TW200643023A/zh unknown
- 2006-03-01 MY MYPI20060872A patent/MY138328A/en unknown
- 2006-03-01 PE PE2006000234A patent/PE20061293A1/es not_active Application Discontinuation
- 2006-03-01 AR ARP060100772A patent/AR053151A1/es unknown
2007
- 2007-08-06 IL IL185078A patent/IL185078A0/en unknown
- 2007-08-08 NO NO20074101A patent/NO20074101L/no not_active Application Discontinuation
- 2007-08-17 CR CR9325A patent/CR9325A/es not_active Application Discontinuation
- 2007-08-30 NI NI200700226A patent/NI200700226A/es unknown
- 2007-08-31 ZA ZA200707526A patent/ZA200707526B/xx unknown

Also Published As

Publication number	Publication date
KR20070107072A (ko)	2007-11-06
CA2599580A1 (en)	2006-09-08
US7288647B2 (en)	2007-10-30
MX2007010715A (es)	2007-10-12
PE20061293A1 (es)	2006-12-22
ZA200707526B (en)	2010-02-24
EP1853611A1 (en)	2007-11-14
AU2006218916A1 (en)	2006-09-08
JP2008531685A (ja)	2008-08-14
CR9325A (es)	2008-01-21
TW200643023A (en)	2006-12-16
US20060199253A1 (en)	2006-09-07
GT200600095A (es)	2006-10-25
CN101133066A (zh)	2008-02-27
IL185078A0 (en)	2007-12-03
RU2007130407A (ru)	2009-04-10
WO2006093743A1 (en)	2006-09-08
MY138328A (en)	2009-05-29
AR053151A1 (es)	2007-04-25
NI200700226A (es)	2008-07-03
BRPI0607390A2 (pt)	2017-08-22

Similar Documents

Publication	Publication Date	Title
DK2292607T3 (da)	2014-06-30	Fremgangsmåde til syntese af organiske forbindelser
CL2008000322A1 (es)	2008-09-05	Proceso para la preparacion de un compuesto derivado de 2-tiazol-2-il-quinolina; compuestos intermediarios; y proceso de preparacion de dichos compuestos intermediarios.
DK1795576T3 (da)	2014-07-14	Fremgangsmåde til fremstilling af carbonhydrider
WO2006099468A3 (en)	2007-04-05	Process for the purification of duloxetine hydrochloride
TWI318622B (en)	2009-12-21	Process for the manufacture of dichloropropanol by chlorination of glycerol
ATE427965T1 (de)	2009-04-15	Antikírper gegen 25-hydroxyvitamin d
EP1898267A4 (en)	2010-03-24	LIQUID DEVELOPER MANUFACTURING PROCESS AND LIQUID DEVELOPER OBTAINED BY THE PROCESS
EP1898268A4 (en)	2010-03-24	METHOD FOR PRODUCING A LIQUID DEVELOPER AND LIQUID DEVELOPER MADE IN THIS METHOD
NO20076030L (no)	2007-12-07	Fremgangsmåte for fremstilling av hydroklorsilaner
NO346368B1 (no)	2022-06-27	En fremgangsmåte for konsentrasjon av alfa-mannosidase.
DK2082054T3 (da)	2012-08-20	Fremgangsmåde til forbedring af udbyttet af celluloseomdannelsesprocesser
DK1843977T3 (da)	2020-07-06	Fremgangsmåde til fremstilling af cæsiumhydroxidopløsninger
CL2007003875A1 (es)	2008-04-18	Compuestos derivados de amidas del acido 3-amino tetrahidrofurano-3-carboxilico; procedimiento de preparacion de dichos compuestos.
FI20055666A0 (fi)	2005-12-12	Prosessi hiilivetykomponentin valmistamiseksi
NO20074101L (no)	2007-09-26	Isolering av CCI-779 fra morvaesker
DK1912961T3 (da)	2013-02-11	Fremgangsmåde til fremstilling af bepromolin
WO2006122020A3 (en)	2007-05-18	Process for production of 4-biphenylyazetidin-2-ones
FR2894958B1 (fr)	2008-04-18	Procede de preparation de difluoroethanol
GB0402262D0 (en)	2004-03-10	Process for the manufacture of organic compounds
NO20055066D0 (no)	2005-10-31	Fremgangsmate for fremstilling av hygienisert organisk slam
ZA200709621B (en)	2008-11-26	Process for the synthesis of organic compounds
FI20050418A (fi)	2006-10-23	Menetelmä sterolien erottamiseksi mäntyöljypiestä
FR2888843B1 (fr)	2012-05-04	Procede de preparation d'un diarylanthracene.
NO20082379L (no)	2008-09-04	Fremgangsmate for fremstilling av renset krystallinsk CCI-779
FR2905692B1 (fr)	2008-10-24	Procede de preparation de ferrates (vi).

Legal Events

Date	Code	Title	Description
2010-09-27	FC2A	Withdrawal, rejection or dismissal of laid open patent application